
February 2013 Autoimmune Disorders


The runners-up in our second annual essay contest share their stories of putting in the extra effort necessary to ensure their patients get the best care possible.



















Depending on a patient's age, communication can present a barrier to effective pain treatment.

Quantity of product and the training of the pharmacy professional are factors to consider in this question.



Clinical studies support the use of these supplements to promote health.

As vitamin D deficiency gets more attention in the media, patients turn to supplements.



Preventive measures and herd immunity are having a major impact on disease prevalence.

Choosing the right anticoagulation agent and duration of therapy remains controversial.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLC
2
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
3
FDA Approves Secukinumab as First IL-17 Biologic for Polymyalgia Rheumatica
4
Adrabetadex Becomes First Therapy Shown to Extend Survival in Infantile-Onset Niemann-Pick Disease Type C
5